Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEURONOX vs BOTOX in Spontaneous Blepharospasm
CTR20160057Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in idiopathic blepharospasm (BEB), sponsored by Medytox Inc.. Started Mar 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on CTR20160057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160057.